Recent Finacing
Recent Raise
T2 Biosystems develops and commercializes the T2MR magnetic‑resonance diagnostic platform and T2Dx benchtop instruments with rapid assays (e.g., T2Candida) that detect pathogens and biomarkers directly from unprocessed clinical samples.
